Skip to main content

Innospec Inc.

IOSP
Exchange
Nasdaq
Industry
Chemicals & Allied Products
SEC CIK
0001054905

No open-market purchases or sales by Innospec Inc. insiders were filed in the last 90 days; 281 institutions reported holding it in 13F filings for Q2 2026, worth $2.00B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Innospec Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Innospec Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Innospec Inc.
NameTitleLast reported holdingLast filingFilings, past year
Cleminson IanEVP & CFO20,357Mar 6, 20263
Blackmore Milton CDirector10,530Mar 6, 20262
PADFIELD LarryDirector9,453Mar 6, 20262
Landless DavidDirector7,632Mar 6, 20262
Poccia ClaudiaDirector6,508Mar 6, 20262
Williams PatrickPRESIDENT & CEO231,535Mar 3, 20263
Jones David B.SVP, GC & CCO14,693Mar 3, 20263
Barnes CorbinSVP, Corporate Dev and IR13,080Mar 3, 20263
Griffin Hardy Louis IIISVP, HUMAN RESOURCES10,161Mar 3, 20263
McRobbie Ian MalcolmSenior VP R&T36,679Feb 25, 20261
Arnold Elizabeth KDirector6,376Feb 25, 20261
Blair GraemeHead of Group Finance–Feb 25, 20261
Parrette Leslie JDirector7,376Feb 24, 20262
Boon Philip JohnExecutive VP Business Ops20,079Feb 24, 20250
PALLER Robert IDirector14,343Feb 28, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 6, 2022 (view filing)Dec 51 dayJones David B.SVP, GC & CCOPPurchase+752$107.99+$81.2K+96.7%1.53K after
Mar 1, 2022 (view filing)Feb 254 daysCleminson IanVP & CFOSSale−2.04K$96.78−$196.9K−8.6%21.6K after4 lots
Mar 1, 2022 (view filing)Feb 254 daysWilliams PatrickPRESIDENT & CEOSSale−11.4K$96.77−$1.11M−6.5%163.8K after4 lots
Mar 1, 2022 (view filing)Feb 254 daysBoon Philip JohnExecutive VP Business OpsSSale−1.51K$96.77−$145.9K−7.8%17.9K after5 lots
Mar 1, 2022 (view filing)Feb 254 daysLandless DavidDirectorSSale−348$96.78−$33.7K−4.6%7.27K after2 lots
Mar 1, 2022 (view filing)Feb 254 daysBlackmore Milton CDirectorSSale−740$96.77−$71.6K−9.3%7.25K after2 lots
Feb 24, 2022 (view filing)Feb 222 daysMcRobbie Ian MalcolmSenior VP R&TSSale−374$99.31−$37.1K−1.0%37.6K after
Nov 15, 2021 (view filing)Nov 114 daysCleminson IanVP & CFOSSale−374$93.61−$35.0K−1.7%21.3K after
Nov 12, 2021 (view filing)Nov 102 daysBlackmore Milton CDirectorSSale−293$93.70−$27.5K−4.3%6.60K after
Nov 12, 2021 (view filing)Nov 93 daysWilliams PatrickPRESIDENT & CEOSSale−12.0K$93.39−$1.12M−6.9%160.7K after3 lots